Pyridineó3,4-b!pyrazinonen

Pyridineó3,4-b!pyrazinonen

Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R2, R6A, R6B and R8 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, synthetic methods, and intermediate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DAVID LOUIS BROWN, ANDREW SIMON BELL, MICHAEL JOHN PALMER, DAFYDD RHYS OWEN, CHRISTOPHER PHILLIPS, YVETTE MARLENE FOBIAN, ROBERT O. HUGHES, JOHN KEITH WALKER, STEVEN EDWARD HEASLEY, JOHN MAJOR MOLYNEAUX, MICHAEL BRENT TOLLEFSON, TODD MICHAEL MADDUX, JOSEPH BLAIR MOON, DONALD JOSEPH ROGIER, BRENT VIRGIL MISCHKE, JOHN NICHOLAS FRESKOS, ERIC JON JACOBSEN, DAVID GRAHAM BROWN
Format: Patent
Sprache:dut
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: wherein R2, R6A, R6B and R8 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, synthetic methods, and intermediates are also disclosed.